GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

ValiRx VAL.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.14p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

ValiRx — daily VAL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View ValiRx on TradingView ↗
Market value
£184,484
Last close × shares
Volume
3.8m
Shares, 9 Nov 2026

About ValiRx

Its shares trade on LSE under the ticker VAL.L. It has been listed since 28 February 2000. In the fiscal year to 31 December 2025, it reported revenue of £31,372 and a net loss of £2.2m. At that date it held total assets of £2.6m and shareholders' equity of £2.9m.

ValiRx Plc operates as a biopharmaceutical company. The company is headquartered in Nuneaton, Warwickshire. The company went IPO on 2000-02-28. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. The company focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company operates in two business segments: drug development and the sale of self-test drug kits. Its product pipeline includes VAL101, VAL201, VAL401 and Nav3. VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth including endometriosis. VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. VAL101 is a therapeutic based on its Gene Inactivation by chromatin engineering (GeneICE) platform. NAV3 Cancer Screening Test enables the detection of cancer cells in tissue samples. The company operates through divisional companies, including ValiPharma, ValiFinn and ValiSeek.

Figures and description from our data supplier, not checked against the company's own report.

More about ValiRx →

Latest on ValiRx

Our reporting

We have not reported on ValiRx yet.

Next results

9 Jun 2027

Due on 9 Jun 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is ValiRx's ticker?

ValiRx trades as VAL.L on LSE, under ISIN GB00BLH13C52.

What was ValiRx's last closing price?

0.14p on 9 Nov 2026. The figure is in GBp and is never converted.

When does ValiRx next report results?

Results are expected on 9 Jun 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.